Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Construction and validation of a bone marrow tissue microarray.

Annette Zimpfer1, Sharon Schönberg, Alessandro Lugli

  • 1Institute of Pathology, University Hospital of Basel, Basel, Switzerland.

Journal of Clinical Pathology
|May 16, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The different face of skin-rash induced by brentuximab vedotin.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2026
Same author

The prognostic value of tumour budding for survival in stage II and III colorectal cancer: a systematic review and meta-analysis.

Histopathology·2026
Same author

Mediastinal grey zone lymphomas: Results of the expert pathological review analysis of a case series enrolled in the multicentre BIOGZL-2020 study in Italy.

British journal of haematology·2026
Same author

CDX2 expression dynamics in tumor clusters: a morpho-molecular biomarker in rectal cancer pretreatment biopsies revealed by sequential immunofluorescence.

Scientific reports·2026
Same author

Case Report of a Lymphocytic Variant Hypereosinophilic Syndrome Mimicking T-Cell Lymphoma: A Diagnostic Challenge and Therapeutic Response to Mepolizumab.

The Australasian journal of dermatology·2026
Same author

Ribosome biogenesis rate, a parameter of sensitivity to chemotherapeutic drugs inhibiting rRNA synthesis.

Oncology reviews·2026
Same journal

Defining biochemical, pathological and molecular factors prognostic in terms of disease control and survival in high-grade extremity soft tissue sarcoma: a scoping review.

Journal of clinical pathology·2026
Same journal

MILGDF: a multi-task, instance-level supervised model for oral squamous cell carcinoma integrating local-global attention and dynamic decision fusion.

Journal of clinical pathology·2026
Same journal

Paediatric B-lymphoblastic leukaemia with low peripheral blasts: a potential diagnostic pitfall.

Journal of clinical pathology·2026
Same journal

MRI-targeted versus systematic needle core biopsies in prostate cancer: a patient-based analysis of potential diagnostic and biologic underestimation.

Journal of clinical pathology·2026
Same journal

Basal plasmacytosis and eosinophilia for distinguishing inflammatory bowel disease from gastrointestinal tuberculosis on mucosal biopsy.

Journal of clinical pathology·2026
Same journal

Assay-dependent variability in free thyroxine (FT4): differential interference related to immunoassay design in a patient with subclinical hypothyroidism.

Journal of clinical pathology·2026
See all related articles

Tissue microarrays (TMAs) are effective for analyzing acute leukaemia, even with small bone marrow samples. This technique allows for high-throughput analysis of leukaemia subtypes and their characteristics.

Area of Science:

  • Hematology
  • Oncology
  • Immunohistochemistry

Background:

  • Tissue microarrays (TMAs) are standard for solid tumor research.
  • Limited data exists on TMA applicability for acute leukaemia analysis.
  • Bone marrow (BM) TMA analysis was performed to address this gap.

Purpose of the Study:

  • To evaluate the feasibility and accuracy of using TMAs for acute leukaemia research.
  • To assess the utility of TMAs for high-throughput analysis of leukaemia markers.

Main Methods:

  • Constructed a BM-TMA from 148 acute leukaemia cases (115 AML, 33 ALL).
  • Performed immunohistochemical analysis using 15 different markers.
  • Validated TMA results by direct comparison with 50 corresponding full tissue sections.

Related Experiment Videos

Main Results:

  • 100% concordance was observed between TMA and full section analyses.
  • 4% of cases and 11% of cores were not evaluable.
  • Acute leukaemia cases on TMA showed expected phenotypic profiles for AML and ALL subtypes.

Conclusions:

  • BM-TMA construction and analysis are feasible despite small biopsy size and bony trabeculae.
  • TMAs are a promising method for high-throughput analysis in leukaemia research.
  • TMAs enable investigation of marker expression and clinicopathological correlations in leukaemia.